Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MediSense's automated glucose monitor gets FDA OK

This article was originally published in Clinica

Executive Summary

Abbott's MediSense subsidiary has received approval from the US FDA to market its Sof-Tact diabetes management system, which incorporates a vacuum-seal device that allows users to draw blood samples from parts of the body other than the pain-sensitive fingertips. Abbott claims the system is the first automated glucose monitor to offer lancing, blood collection and glucose measurement with a single press of a button. Furthermore, it incorporates new strip technology that requires less blood than conventional tests.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT075222

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel